SCHEMBL21311779

SCHEMBL21311779

c1ccc2c(c1)NC1CCCCC1S2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.47
TSHR P16473 2/20 0.44
LMNA P02545 1/20 0.44
RAB9A P51151 1/20 0.38
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
NPC1 O15118 1/20 0.37
BRD4 O60885 1/20 0.36
CREBBP Q92793 1/20 0.36
HSD17B10 Q99714 4/20 0.35
ALDH1A1 P00352 4/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
GLA P06280 1/20 0.33
PARP1 P09874 1/20 0.33
GAA P10253 4/20 0.32
MAPK1 P28482 2/20 0.32
POLB P06746 2/20 0.32
ALOX15 P16050 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9636590 0.77 PARP1 (0.53) TSHRLMNAHSD17B10ALDH1A1SMN1; SMN2
SCHEMBL30468213 0.73 IDO1 (0.48) IDO1TSHRLMNARAB9AMEN1
SCHEMBL29051604 0.73 IDO1 (0.48) IDO1TSHRLMNARAB9AMEN1
SCHEMBL21311879 0.72 TSHR (0.41) TSHRLMNAMEN1KMT2APARP1
SCHEMBL9635301 0.72 RYR2 (0.35) TSHRLMNAHSD17B10ALDH1A1GAA
SCHEMBL29051608 0.71 IDO1 (0.47) IDO1TSHRLMNARAB9AMEN1
SCHEMBL30468205 0.71 IDO1 (0.47) IDO1TSHRLMNARAB9AMEN1
SCHEMBL29051627 0.71 IDO1 (0.47) IDO1TSHRLMNARAB9AMEN1
SCHEMBL30468219 0.71 IDO1 (0.47) IDO1TSHRLMNARAB9AMEN1
SCHEMBL27233112 0.71 IDO1 (0.47) IDO1TSHRLMNARAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019161781-A1 RECEPTOR ANTAGONIST, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USAGE THEREOF 北京泰德制药股份有限公司 2019-08-29 WO disclosed